{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:57:59Z","timestamp":1787320679879,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/chi.0b013e3180335ae4","type":"journal-article","created":{"date-parts":[[2007,4,17]],"date-time":"2007-04-17T04:02:15Z","timestamp":1176782535000},"page":"628-635","source":"Crossref","is-referenced-by-count":26,"title":["Response and Remission in Adolescent Mania"],"prefix":"10.1016","volume":"46","author":[{"given":"NICK C.","family":"PATEL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIELLE M.","family":"PATRICK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERIC A.","family":"YOUNGSTROM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEPHEN M.","family":"STRAKOWSKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MELISSA P.","family":"DELBELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/chi.0b013e3180335ae4_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopsych.2005.03.019","article-title":"Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children","volume":"58","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/104454603321666162","article-title":"Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference","volume":"13","author":"Carlson","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/chi.0b013e3180335ae4_bib4","unstructured":"Cooperberg M (2001), Clinically significant change for outcome measures used with pediatric bipolar disorders. Doctoral dissertation, Case Western Reserve University, Cleveland"},{"key":"10.1097\/chi.0b013e3180335ae4_bib5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.npp.1300950","article-title":"Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study","volume":"31","author":"DelBello","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1097\/chi.0b013e3180335ae4_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania","volume":"45","author":"DelBello","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"DelBello","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1399-5618.2001.030201.x","article-title":"Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset","volume":"3","author":"DelBello","year":"2001","journal-title":"Bipolar Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.CHI.0000046893.27264.53","article-title":"Combination lithium and divalproex sodium in pediatric bipolarity","volume":"42","author":"Findling","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder","volume":"11","author":"Frazier","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/chi.0b013e3180335ae4_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00004583-199203000-00011","article-title":"The Mania Rating Scale: can it be used in children? A preliminary report","volume":"31","author":"Fristad","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10401239509149039","article-title":"The Mania Rating Scale (MRS): further reliability and validity studies with children","volume":"7","author":"Fristad","year":"1995","journal-title":"Ann Clin Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archpsyc.61.5.459","article-title":"Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype","volume":"61","author":"Geller","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004583-200104000-00014","article-title":"Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections","volume":"40","author":"Geller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib15","series-title":"User's Guide to the Medical Literature","author":"Guyatt","year":"2002"},{"key":"10.1097\/chi.0b013e3180335ae4_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1399-5618.2003.00033.x","article-title":"Statistical methods for longitudinal research on bipolar disorders","volume":"5","author":"Hennen","year":"2003","journal-title":"Bipolar Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/0022-006X.67.3.300","article-title":"Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives","volume":"67","author":"Jacobson","year":"1999","journal-title":"J Consult Clin Psychol"},{"key":"10.1097\/chi.0b013e3180335ae4_bib19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/01.CHI.0000070247.24125.24","article-title":"Lithium treatment of acute mania in adolescents: a large open trial","volume":"42","author":"Kafantaris","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib20","first-page":"25","article-title":"Defining and improving response to treatment in patients with bipolar disorder","volume":"65","author":"Keck","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib21","first-page":"130","article-title":"Definition, evaluation, and management of treatment refractory mania","volume":"35","author":"Keck","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"10.1097\/chi.0b013e3180335ae4_bib22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.155.5.646","article-title":"12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode","volume":"155","author":"Keck","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib24","series-title":"Evaluating Medical Tests: Objective and Quantitative Guidelines","author":"Kraemer","year":"1992"},{"key":"10.1097\/chi.0b013e3180335ae4_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1399-5618.2000.20309.x","article-title":"Bipolar disorder during adolescence and young adulthood in a community sample","volume":"2","author":"Lewinsohn","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/sim.4780050516","article-title":"Partitioning methods for classification and decision making in medicine","volume":"5","author":"Marshall","year":"1986","journal-title":"Stat Med"},{"key":"10.1097\/chi.0b013e3180335ae4_bib27","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/sim.4780142405","article-title":"A program to implement a search method for identification of clinical subgroups","volume":"14","author":"Marshall","year":"1995","journal-title":"Stat Med"},{"key":"10.1097\/chi.0b013e3180335ae4_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-0327(02)00080-0","article-title":"Relationships among measures of treatment outcome in depressed patients","volume":"76","author":"Mulder","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib29","first-page":"839","article-title":"Clinical Global Impressions (CGI) scale","volume":"21","author":"NIMH","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1097\/chi.0b013e3180335ae4_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5618.2005.00204.x","article-title":"Divalproex sodium for pediatric mixed mania: a 6-month prospective trial","volume":"7","author":"Pavuluri","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/cap.2006.16.336","article-title":"A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder","volume":"16","author":"Pavuluri","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/chi.0b013e3180335ae4_bib32","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jad.2004.05.017","article-title":"Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania","volume":"82","author":"Pavuluri","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord"},{"key":"10.1097\/chi.0b013e3180335ae4_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1097\/chi.0b013e3180335ae4_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpsyc.55.1.49","article-title":"Twelve-month outcome after a first hospitalization for affective psychosis","volume":"55","author":"Strakowski","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib38","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.160.12.2099","article-title":"The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence","volume":"160","author":"Tohen","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib39","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4088\/JCP.v66n1209","article-title":"Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale","volume":"66","author":"Tolin","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib40","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"},{"key":"10.1097\/chi.0b013e3180335ae4_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib42","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00004583-200210000-00012","article-title":"An open-label trial of divalproex in children and adolescents with bipolar disorder","volume":"41","author":"Wagner","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1097\/chi.0b013e3180335ae4_bib44","first-page":"S245","article-title":"Identifying the most sensitive measures and definitions of outcome for pediatric bipolar disorder","volume":"30","author":"Youngstrom","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1097\/chi.0b013e3180335ae4_bib45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1207\/S15374424JCCP3104_15","article-title":"Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years","volume":"31","author":"Youngstrom","year":"2002","journal-title":"J Clin Child Adolesc Psychol"},{"key":"10.1097\/chi.0b013e3180335ae4_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1207\/s15374424jccp3403_4","article-title":"Toward an evidence-based assessment of pediatric bipolar disorder","volume":"34","author":"Youngstrom","year":"2005","journal-title":"J Clin Child Adolesc Psychol"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T06:20:00Z","timestamp":1568355600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709617226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0890856709617226"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e3180335ae4","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}